Cargando…
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea: A systematic review
Clozapine is considered the golden standard in the treatment of therapy‐resistant schizophrenia; however, it associated with bothersome side effects such as sialorrhea. Current evidence suggests that the sublingual use of atropine seems to be safe and effective and could be considered as a first‐lin...
Autores principales: | Van der Poorten, Thomas, De Hert, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878073/ https://www.ncbi.nlm.nih.gov/pubmed/31788260 http://dx.doi.org/10.1002/ccr3.2431 |
Ejemplares similares
-
The sublingual use of atropine in the treatment of clozapine‐induced sialorrhea
por: Darriba, H. Becerra
Publicado: (2021) -
Examining the Role of Sublingual Atropine for the Treatment of Sialorrhea in Patients with Neurodevelopmental Disabilities: A Retrospective Review
por: Petkus, Kayla Durkin, et al.
Publicado: (2023) -
Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022) -
Thrombocytopenia associated with clonidine in a case of clozapine-induced sialorrhea
por: Leung, Jonathan G., et al.
Publicado: (2020) -
Low-dose Amisulpride for Debilitating Clozapine-induced Sialorrhea: Case Series and Review of Literature
por: Kulkarni, Ranganath R.
Publicado: (2015)